Hexagon Capital Partners LLC 10x Genomics, Inc. Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
A detailed history of Hexagon Capital Partners LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 79 shares of TXG stock, worth $1,177. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79
Previous 106
25.47%
Holding current value
$1,177
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
292Shares Held
96.6MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$163 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$160 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$96.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$95.3 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$95 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.42B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...